Loading organizations...
LabTech develops and manufactures advanced laboratory instruments, offering comprehensive solutions that include analytical tools, automated sample preparation systems, and lab engineering services. The company integrates multifunctional sample preparation technologies with fully automated analytical platforms, providing complete laboratory setups and specialized consumables for various scientific applications.
Founded in 2002 by Dr. Ke Hu, LabTech emerged from his extensive background in mass spectrometry research and development. The initial focus involved foundational laboratory equipment like water chillers and hotplates. This deep technical insight and commitment to instrument innovation guided its evolution into a provider of integrated, high-precision laboratory solutions.
LabTech serves a global customer base across critical sectors such as environmental monitoring, food safety, disease control, and semiconductor analysis. The company’s vision is to advance the future of science for a healthier world, aiming to be a premier provider of laboratory analytical instruments that deliver increasingly accurate, efficient, and intelligent analytical workflows.
Labtech has 1 tracked investment across 1 company. The latest tracked deal is $20.0M Other Equity / Series C in Fever in July 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 5, 2018 | Fever | $20.0M Other Equity / Series C | Javier Nuche, Labtech | 14W, Accel |